BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4700951)

  • 1. [Drug therapy of peripheral arterial occlusive diseases in the lower extremities using Tebonin].
    Perinović M; Vasiljević M; Grujić M
    Ther Ggw; 1973 Mar; 112(3):434-6 passim. PubMed ID: 4700951
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of arterial occlusive disease of the lower limbs using Tebonin].
    Kandziora J
    Z Allgemeinmed; 1973 May; 49(14):682-5. PubMed ID: 4754639
    [No Abstract]   [Full Text] [Related]  

  • 3. [Study on the efficacy of ginkgo biloba extract, magnesium and levo-arginine in the treatment of patients with 2d stage arteriopathies. A preliminary study].
    Michelini S; Micci A; Failla A; Moneta G; Ottaviani A
    Minerva Cardioangiol; 1998 Sep; 46(9):319-20. PubMed ID: 10021862
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evaluation of delayed-action Tebonin with the study of muscle flow, using xenon 133].
    Matteoni R; Reale R; Lauri D; Sirolli C; Tata MV
    Minerva Cardioangiol; 1973 Apr; 21(4):264-71. PubMed ID: 4710123
    [No Abstract]   [Full Text] [Related]  

  • 5. [Improvement of walking disability and conservative treatment. Guiding principles for drug treatment of chronic arterial occlusive disease (stage I and IIb)].
    Heinrich F
    Fortschr Med; 1984 Sep; 102(36):74-5. PubMed ID: 6489898
    [No Abstract]   [Full Text] [Related]  

  • 6. [Ginkgo-biloba in the therapy of vascular diseases].
    Sorbini E
    Minerva Med; 1973 Nov; 64(79 Suppl):4201-8. PubMed ID: 4592298
    [No Abstract]   [Full Text] [Related]  

  • 7. [Role and place of prolonged intra-arterial infusion in the treatment of obliterating arterial diseases of the lower extremities].
    Belichenko IA; Kungurtsev VV; Dibirov MD
    Khirurgiia (Mosk); 1980 Mar; (3):48-51. PubMed ID: 7366097
    [No Abstract]   [Full Text] [Related]  

  • 8. [Drug therapy of chronic arterial occlusive diseases of the lower extremities with butalamine-HCl].
    Kling H
    Fortschr Med; 1979 May; 97(19):926-8. PubMed ID: 109382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of raubasine in treatment of peripheral arterious circulation disorders].
    Koch G; Eide M
    Med Klin; 1972 Nov; 67(46):1519-21. PubMed ID: 4265445
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ginkgo biloba extract in the treatment of arteriopathy of the lower extremities. A 65-week trial].
    Bauer U
    Presse Med; 1986 Sep; 15(31):1546-9. PubMed ID: 2947095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of acetylcholine in occlusive diseases of the arteries of the lower extremities].
    Mizun PG
    Vrach Delo; 1986 Jul; (7):49-51. PubMed ID: 3750997
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical tests using veno-tebonin in venous diseases of the leg].
    Giensch H; Heits E
    Med Monatsschr; 1970 Jun; 24(6):272-3. PubMed ID: 5525115
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinico-instrumental evaluation of ciclonicate in the therapy of obliterating arteriopathies of the lower extremities in Fontaine's stage II].
    Feliciotti F; De Carolis G; Mariotti C; Mingolla F
    Ann Ital Chir; 1983; 55(5):493-7. PubMed ID: 6673630
    [No Abstract]   [Full Text] [Related]  

  • 14. [On the therapy of peripheral circulatory disorders with the new angioactivator Tebonin of plant origin].
    Krammer F
    Med Welt; 1966 Jul; 28():1524-8. PubMed ID: 5984513
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical and hemodynamic evaluation of the action of pentoxifylline in patients with obstructive arteriopathy of the lower extremities].
    Zaccaria A; Antonini M; Marciani A; Taurino M; Speziale F; Spartera C
    Ric Clin Lab; 1981; 11 Suppl 1():381-6. PubMed ID: 7188126
    [No Abstract]   [Full Text] [Related]  

  • 16. [1st experiences with prostaglandin E1 long-term intra-arterial perfusion in advanced arterial occlusive disease of the lower extremities stage IV].
    Gruss JD; Kawai S; Karadedos C; Bartels D
    Dtsch Med Wochenschr; 1978 Oct; 103(41):1624-5. PubMed ID: 699778
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of Prodectin (pyridinolcarbamate) treatment of the circulation rate in obliterating arterial diseases of the lower extremities.
    Fényes G; Gótzy G; Fehrentheil L
    Ther Hung; 1975; 23(2):64-66. PubMed ID: 1188705
    [No Abstract]   [Full Text] [Related]  

  • 18. [The evaluation by video capillaroscopy of the efficacy of a Ginkgo biloba extract with L-arginine and magnesium in the treatment of trophic lesions in patients with stage-IV chronic obliterating arteriopathy].
    Pepe C; Rozza A; Veronesi G
    Minerva Cardioangiol; 1999 Jun; 47(6):223-30. PubMed ID: 10522149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Functional results of oral dusodril therapy of obliterating arteriopathy of the lower extremities. Comparison of the angiogram, plethysmogram and Doppler ultrasound].
    Weidinger P
    Med Welt; 1983 Apr; 34(17):531-4. PubMed ID: 6865725
    [No Abstract]   [Full Text] [Related]  

  • 20. [The use of Vasaprostan (prostaglandin E1) in treating patients with obliterating arterial diseases of the lower extremities].
    Lebedev LV; Afonin DN
    Vestn Khir Im I I Grek; 1993; 150(5-6):153-7. PubMed ID: 8091569
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.